In light of the recent news, Penn oncologist Susan Domcheck debunks a few myths about men and breast cancer.

Villanova University professor Dr. Qianhong Wu has invented a “Smart Brain” that simulates exactly what happens in the brain during head injuries.

By treating canines as patients, the One Health Company wants to cure cancer in dogs and eventually in people.

Advocates with Philly nonprofit Maternity Care Coalition hit the road to visit pregnant women and new moms at home and in prison.

The refurbished facility features next-generation technologies designed to streamline R&D and the manufacturing of new medicines.

The local company is launching a series of clinical trials that could lead to new treatments for breast cancer and other hormone-induced diseases.

Philly expert Dr. Alberto Esquenazi, who switches between a prosthetic arm and hook, says the bionics boom is not only good but also necessary.

The Thomas Jefferson University leader has dedicated her career to healthcare parity.

With automated payment technology, Greenphire is making it easier to enroll and get paid for participating in clinical trials.

The nationwide initiative will fund nine city projects aimed at ending preventable maternal deaths.

John Furey helped propel Spark to a groundbreaking FDA approval. Can he do the same for another Philly biotech company?

Proscia has developed software and artificial intelligence tools to make pathology more accurate and efficient.

Spark Therapeutics board member Steve Altschuler shares his thoughts on the challenges of big pharma acquisitions.

The two local companies are combining new tech and genetic testing to improve outcomes for patients.

The first-of-its-kind space boasts a 25,000-square-foot training facility that could help close the local bioprocessing workforce gap.